MedPath

Telerehab activity intervention for people with Guillain Barre Syndrome

Not Applicable
Active, not recruiting
Conditions
Guillain Barre Syndrome
Neurological - Other neurological disorders
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Registration Number
ACTRN12621001178831
Lead Sponsor
AUT University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
8
Inclusion Criteria

Adults greater than or equal to 18 years
• GBS onset more than 2 years previously
• Community-dwelling
• Walks in the community (Rivermead Mobility Index of greater than 10)
• Experiences fatigue (Fatigue Severity Scale greater than or equal to 4)
• Resident in New Zealand
• Access to the internet

Exclusion Criteria

- Currently receiving rehabilitation
• Has another health condition that impacts physical activity
• Has a contraindication for physical activity (as indicated by the Physical Activity Readiness Questionnaire (PAR-Q)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue severity - assessed by Fatigue Severity Scale[baseline (at week 0, 2 and 4), during the intervention period (at weeks 8, 12 and 16) and during followup phase (at weeks 18, 20, 22 and 40)];Daily steps as recorded by wrist worn fitbit[baseline (at week 0, 2 and 4), during the intervention period (at weeks 8, 12 and 16) and during followup phase (at weeks 18, 20, 22 and 40)];Personal wellbeing index as indicated by online questionnaire - Personal wellbeing index[baseline (at week 0, 2 and 4), during the intervention period (at weeks 8, 12 and 16) and during followup phase (at weeks 18, 20, 22 and 40)]
Secondary Outcome Measures
NameTimeMethod
Exercise self efficacy (additional primary outcome) - assessed via online questionnaire Exercise self-efficacy scale[baseline (at week 0, 2 and 4), during the intervention period (at weeks 8, 12 and 16) and during followup phase (at weeks 18, 20, 22 and 40)];sedentary time (additional primary outcome) as recorded by wrist worn fit bit [baseline (at week 0, 2 and 4), during the intervention period (at weeks 8, 12 and 16) and during followup phase (at weeks 18, 20, 22 and 40)];Acceptability - assessed via one on one semi-structured interviews with each participant<br><br>[between 22 and 40 weeks];Feasibility - assessed via one on one semi-structured interviews with each participant[Between 22 and 40 weeks]
© Copyright 2025. All Rights Reserved by MedPath